Phase 3 Dilated Cardiomyopathy Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Symptomatic Genetic Dilated Cardiomyopathy
Kardigan, Inc.332 enrolled33 locationsNCT07210723
Recruiting
Phase 3
Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
Dilated Cardiomyopathy
Jimma University112 enrolled1 locationNCT06250257
Completed
Phase 3
Evaluation of "Early Disease" in Familial Dilated Cardiomyopathy
Familial dilated cardiomyopathy
St Vincent's Hospital, Darlinghurst64 enrolled1 locationACTRN12605000204640